ANTHEM
NIFTY500
Anthem Biosciences Ltd.
Pharma · NSE
₹784.65
1Y—
52-week range
₹579 – ₹874
From 52w high
-10.2%
RSI (14)
69.3
vs SMA 50 / 200
↑ 50 · ↓ 200
PE
91.7
Forward PE
63.4
ROE
—
Profit margin
24.2%
D/E
4.00
Dividend yield
—
Quality score
24/100
Revenue growth
-15.0%
Earnings growth
-25.8%
For informational purposes only. Not investment advice. VivaTrades is not a SEBI-registered Investment Adviser or Research Analyst. Market data sourced from public feeds; consult a registered adviser before any investment decision.